Grants Search Results

This grant supports a research coordinator to improve patient outcomes and care.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure

When eligible children with cancer are treated on clinical trials, it provides the best opportunity to observe response to treatment while gathering data that could help improve future therapy. This grant funds trained research staff to enroll eligible children with cancer onto clinical trials, and to collect and manage the research data.

Access to early phase trials is vital to the treatment of pediatric cancers that have relapsed or do not respond to standard therapies. The pediatric oncology department at Children's Hospital and Research Center Oakland has made strides to develop an early phase therapeutics program for brain tumors, other solid tumors and relapsed leukemia in conjunction with collaborators on the West Coast. This grant supports the infrastructure to start and maintain the program.

This grant funds a pediatric specific pharmacist at this institution to improve patient outcomes and care.

This grant supports a Clinical Research Associate dedicated to Phase I, II, and III brain tumor clinical trials, to ensure that more kids can be treated on clinical trials.

This grant supportss a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials. This support of necessary personnel has significantly increased clinical trial participation for patients who otherwise might not have access to them.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a clinical research coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution. The program provides survivors the support, treatment and education they need to prevent and address these late effects.

This grant supports an adolescent-young Adult (AYA) liaison to ensure that more AYAs can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to help establish Nevada's first Pediatric Brain Tumor Program.

Genetic studies have identified the molecular causes of childhood cancers such as T-cell leukemia and neuroblastoma. A recurrent theme in these cancers is abnormal activation of the MYC gene. Accordingly, researchers like Dr. Wendel have spent much time and effort in trying to identify inhibitors of MYC as they believe these could be very powerful therapies for these childhood cancers. Dr. Wendel and his colleagues recently found a new way to block the production of MYC using a natural compound. The natural product is rare and hard to come by and therefore Dr. Wendel and his colleagues are exploring ways to generate synthetic drugs based on this plant product. With support from the St. Baldrick’s Foundation they are working to bring this new strategy to the clinic. They focus especially on heavily pre-treated and relapsed childhood leukemia because affected children have few options and they hope to make a difference.